Alpha Teknova (TKNO) Surged Following Accelerated Demand

Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets continued their momentum that began in early April, reaching new all-time highs in the third quarter. The Conestoga Micro-Cap Composite returned 11.7% net-of-fees in the third quarter, compared to the Russell Microcap Growth Index’s return of 19.9%. Please check the top 5 holdings of the fund for a better understanding of their best picks for 2025.

In its third-quarter 2025 investor letter, Conestoga Capital Advisors highlighted stocks such as Alpha Teknova, Inc. (NASDAQ:TKNO). Alpha Teknova, Inc. (NASDAQ:TKNO) produces critical reagents for the life science market for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The one-month return of Alpha Teknova, Inc. (NASDAQ:TKNO) was 1.13%, and its shares lost 18.73% of their value over the last 52 weeks. On October 17, 2025, Alpha Teknova, Inc. (NASDAQ:TKNO) stock closed at $5.13 per share, with a market capitalization of $274.533 million.

Conestoga Capital Advisors stated the following regarding Alpha Teknova, Inc. (NASDAQ:TKNO) in its third quarter 2025 investor letter:

“Alpha Teknova, Inc. (NASDAQ:TKNO) is a leading provider of critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Shares have rallied as demand for life sciences reagents and critical raw materials have rebounded, particularly in biopharma and advanced therapies. Investor sentiment improved with progress toward profitability and positive long-term exposure to cell and gene therapy development.”

Alpha Teknova, Inc. (NASDAQ:TKNO) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 11 hedge fund portfolios held Alpha Teknova, Inc. (NASDAQ:TKNO) at the end of the second quarter, which was 15 in the previous quarter. Alpha Teknova, Inc.’s (NASDAQ:TKNO) total revenue for Q2 2025 reached $10.3 million, up 7% from $9.6 million in Q2 2024. While we acknowledge the risk and potential of Alpha Teknova, Inc. (NASDAQ:TKNO) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Alpha Teknova, Inc. (NASDAQ:TKNO) and that has 10,000% upside potential, check out our report about this cheapest AI stock.

In another article, we covered Alpha Teknova, Inc. (NASDAQ:TKNO) and shared Prosper Stars & Stripes’ views on the company in the previous quarter. In addition, please check out our hedge fund investor letters Q3 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.